[Ertapenem]

Rev Esp Quimioter. 2007 Sep;20(3):277-99.
[Article in Spanish]
No abstract available

Publication types

  • Review

MeSH terms

  • Adolescent
  • Adult
  • Age Factors
  • Aged
  • Anti-Bacterial Agents / adverse effects
  • Anti-Bacterial Agents / economics
  • Anti-Bacterial Agents / pharmacology
  • Anti-Bacterial Agents / therapeutic use*
  • Bacteria / drug effects
  • Bacterial Infections / drug therapy*
  • Cell Wall / drug effects
  • Child
  • Diabetes Complications / drug therapy
  • Double-Blind Method
  • Drug Costs
  • Drug Synergism
  • Ertapenem
  • Female
  • Humans
  • Male
  • Obesity / metabolism
  • Pregnancy
  • Randomized Controlled Trials as Topic / statistics & numerical data
  • Tissue Distribution
  • beta-Lactam Resistance
  • beta-Lactams / adverse effects
  • beta-Lactams / economics
  • beta-Lactams / pharmacology
  • beta-Lactams / therapeutic use*

Substances

  • Anti-Bacterial Agents
  • beta-Lactams
  • Ertapenem